Rho GTPase-activating protein 35 rs1052667 polymorphism and osteosarcoma risk and prognosis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zhao, Jinmin ^a,b   Xu, Hua ^b   He, Maolin ^a,b   Wang, Zhe ^a,b   Wu, Yang ^a,b  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 35; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ARHGAP35 PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; REPRESSOR PROTEIN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MALE; METASTASIS; OSTEOSARCOMA; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; SURVIVAL TIME; TUMOR DIFFERENTIATION; ALLELE; CHINA; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; GENETICS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; SURVIVAL RATE;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; CHINA; DISEASE-FREE SURVIVAL; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OSTEOSARCOMA; POLYMORPHISM, GENETIC; REPRESSOR PROTEINS; SURVIVAL RATE;

EID: 84923002193     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/396947     Document Type: Article

References (32)

1. R. Gorlick, K. Janeway, S. Lessnick, R. L. Randall, and N. Marina, "Childrens oncology groups 2013 blueprint for research: bone tumors, " Pediatric Blood and Cancer, vol. 60, no. 6, pp. 1009-1015, 2013.
2. D. S. Geller and R. Gorlick, "Osteosarcoma: a review of diagnosis, management, and treatment strategies, " Clinical Advances in Hematology and Oncology, vol. 8, no. 10, pp. 705-718, 2010.
3. Y. Cho, G. Jung, S. Chung, J. Kim, and Y. Choi, "Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution, " Clinics in Orthopedic Surgery, vol. 3, no. 1, pp. 48-54, 2011.
4. F. Lamoureux, V. Trichet, C. Chipoy, F. Blanchard, F. Gouin, and F. Redini, "Recent advances in themanagement of osteosarcoma and forthcoming therapeutic strategies, " Expert Review of Anticancer Therapy, vol. 7, no. 2, pp. 169-181, 2007.
5. Z. Chang, R. Song, S. Xu, M. Xu, and X. Yu, "CD 152 gene polymorphisms and risk of osteosarcoma in Chinese population, " Tumor Biology, 2014.
6. Z. Wang, P. Wen, X. Luo et al., "Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population, " Tumour Biology, vol. 35, no. 4, pp. 3605-3610, 2014.
7. T. C. Hou, J. J. Lin, H. C. Wen, L. C. Chen, S. P. Hsu, and W. S. Lee, "Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway, " Biochemical Pharmacology, vol. 85, no. 3, pp. 376-384, 2013.
8. I. Oinuma, K. Kawada, K. Tsukagoshi, and M. Negishi, "Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation, "Molecular Biology of the Cell, vol. 23, no. 8, pp. 1593-1604, 2012.
9. K. L. Grinnell and E. O. Harrington, "Interplay between FAK, PKCδ, and p190RhoGAPin the regulation of endothelial barrier function, "Microvascular Research, vol. 83, no. 1, pp. 12-21, 2012.
10. J. Selva and G. Egea, "Ethanol increases p190RhoGAP activity, leading to actin cytoskeleton rearrangements, " Journal of Neurochemistry, vol. 119, no. 6, pp. 1306-1316, 2011.
11. T. Nemeth, K. Futosi, C. Hably et al., "Neutrophil functions and autoimmune arthritis in the absence of p190RhoGAP: Generation and analysis of a novel null mutation in mice, " Journal of Immunology, vol. 185, no. 5, pp. 3064-3075, 2010.
12. H. Naoe, K. Araki, O. Nagano et al., "The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation, " Molecular and Cellular Biology, vol. 30, no. 16, pp. 3994-4005, 2010.
13. S. A. S. Manchinelly, J. A. Miller, L. Su et al., "Mitotic downregulation of p190RhoGAP is required for the successful completion of cytokinesis, " Journal of Biological Chemistry, vol. 285, no. 35, pp. 26923-26932, 2010.
14. A. Tomar, S. Lim, Y. Lim, and D. D. Schlaepfer, "A FAKp120RasGAP-p190RhoGAP complex regulates polarity in migrating cells, " Journal of Cell Science, vol. 122, part 11, pp. 1852-1862, 2009.
15. W. T. Arthur and K. Burridge, "RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity, " Molecular Biology of the Cell, vol. 12, no. 9, pp. 2711-2720, 2001.
16. G. A. Wildenberg, M. R. Dohn, R. H. Carnahan et al., "p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho, " Cell, vol. 127, no. 5, pp. 1027-1039, 2006.
17. A. Mammoto, S. Huang, and D. E. Ingber, "Filamin links cell shape and cytoskeletal structure to Rho regulation by controlling accumulation of p190RhoGAP in lipid rafts, " Journal of Cell Science, vol. 120, no. 3, pp. 456-467, 2007.
18. A. K. Fordjour and E. O. Harrington, "PKCδ influences p190 phosphorylation and activity: events independent of PKCδ-mediated regulation of endothelial cell stress fiber and focal adhesion formation and barrier function, " Biochimica et Biophysica Acta-General Subjects, vol. 1790, no. 10, pp. 1179-1190, 2009.
19. C. Shen, H. Chen, M. Lin et al., "Breast tumor kinase phosphorylates p190RhoGAP to regulate Rho and ras and promote breast carcinoma growth, migration, and invasion, " Cancer Research, vol. 68, no. 19, pp. 7779-7787, 2008.
20. R. M. Wolf, N. Draghi, X. Liang et al., "p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human Chromosome 19q13. 3, " Genes and Development, vol. 17, no. 4, pp. 476-487, 2003.
21. A. Tikoo, S. Czekay, C. Viars et al., "p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13. 3 that is reportedly deleted in some gliomas, " Gene, vol. 257, no. 1, pp. 23-31, 2000.
22. X. Long, D. Zhao, C. Wang et al., "Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma, " Epidemiology, vol. 24, no. 5, pp. 671-681, 2013.
23. X. Long, J. Yao, Z. Zeng et al., "Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma, " Hepatology, vol. 58, no. 1, pp. 171-181, 2013.
24. A. C. Broders, "Squamous cell epithelioma of the skin: a study of 256 cases, " Annals of Surgery, vol. 73, no. 2, pp. 141-160, 1921.
25. A. F. Mavrogenis, C. N. Abati, C. Romagnoli, and P. Ruggieri, "Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma, " Clinical Orthopaedics and Related Research, vol. 470, no. 6, pp. 1735-1748, 2012.
26. H. Tamura, M. Fukada, A. Fujikawa, and M. Noda, "Protein tyrosine phosphatase receptor type Z is involved in hippocampus-dependent memory formation through dephosphorylation at Y1105 on p190 RhoGAP, " Neuroscience Letters, vol. 399, no. 1-2, pp. 33-38, 2006.
27. W. T. Arthur, L. A. Petch, and K. Burridge, "Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism, " Current Biology, vol. 10, no. 12, pp. 719-722, 2000.
28. K. Ludwig and S. J. Parsons, "The tumor suppressor, p190RhoGAP, differentially initiates apoptosis and confers docetaxel sensitivity to breast cancer cells, " Genes and Cancer, vol. 2, no. 1, pp. 20-30, 2011.
29. F. Mignone, C. Gissi, S. Liuni, and G. Pesole, "Untranslated regions of mRNAs, " Genome Biology, vol. 3, no. 3, 2002.
30. H. Notsuda, A. Sakurada, C. Endo et al., "p190A RhoGAP is involved in EGFR pathways and promotes proliferation, invasion and migration in lung adenocarcinoma cells, " International Journal of Oncology, vol. 43, no. 5, pp. 1569-1577, 2013.
31. I. Molina-Ortiz, R. A. Bartolome, P. Hernandez-Varas, G. P. Colo, and J. Teixido, "Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA, " Journal of Biological Chemistry, vol. 284, no. 22, pp. 15147-15157, 2009.
32. G. Chakravarty, D. Roy, M. Gonzales, J. Gay, A. Contreras, and J. M. Rosen, "p190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer, " Cell Growth and Differentiation, vol. 11, no. 7, pp. 343-354, 2000.